Literature DB >> 22963206

New insights into childhood Vernal keratoconjunctivitis-associated factors.

Riccardina Tesse1, Laura Spadavecchia, Pietro Fanelli, Claudia Paglialunga, Manuela Capozza, Biagio Favoino, Lucio Armenio, Luciano Cavallo.   

Abstract

The purpose of this study was to test for detectable serum levels of antibodies usually associated with immune-related diseases in children with Vernal keratoconjunctivitis (VKC) and seek for their family history of allergies and autoimmune disorders. The association of human leukocyte antigens (HLA) with VKC was also investigated. We enrolled 181 VKC children and assessed total and specific IgE, antithyroglobulin (AbTG), antithyroidperoxidase (AbTPO), antitransglutaminase (tTG), and antinuclear antibodies (ANA) by standard procedures. Class I and II HLA typing was also carried out following standard protocols, and it was compared with that of healthy subjects. Patients were positive for AbTG (22%), AbTPO (14.6%), and ANA (15.8%), and AbTG positivity was associated with VKC severity (mean ocular score ± SD positive vs. negative: 6.56 ± 2.1 vs. 4.82 ± 2.1; p = 0.03). We found that 12.2% of VKC cases had a positive family history for psoriasis, 6.4% for other cases of VKC, and 5.2% for thyroiditis, while 50.2% of them were atopic. The expression of HLA class I B37 was significantly higher in VKC patients than in controls (7.1% vs. 2.1%, p = 0.04), although not confirmed after multiple antigens testing analysis. Our study suggests a role of common components associated with immune-based diseases in the clinical expression of VKC.
© 2012 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22963206     DOI: 10.1111/j.1399-3038.2012.01281.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  5 in total

1.  Higher risk of myasthenia gravis in patients with thyroid and allergic diseases: a national population-based study.

Authors:  Jiann-Horng Yeh; Huang-Tsung Kuo; Hsuan-Ju Chen; Yen-Kung Chen; Hou-Chang Chiu; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

2.  Increased incidence of thyroid dysfunction and autoimmunity in patients with vernal keratoconjunctivitis.

Authors:  Stefano Stagi; Neri Pucci; Laura Di Grande; Cinzia de Libero; Roberto Caputo; Stefano Pantano; Ivan Mattei; Francesca Mori; Maurizio de Martino; Elio Novembre
Journal:  Int J Endocrinol       Date:  2014-07-20       Impact factor: 3.257

3.  Risk of allergic conjunctivitis in patients with type 1 diabetes mellitus: a population-based retrospective cohort study.

Authors:  Yin-Huei Chen; Cheng-Li Lin; Da-Tian Bau; Yi-Chih Hung
Journal:  BMJ Open       Date:  2017-06-19       Impact factor: 2.692

4.  Stability and Safety Traits of Novel Cyclosporine A and Tacrolimus Ophthalmic Galenic Formulations Involved in Vernal Keratoconjunctivitis Treatment by a High-Resolution Mass Spectrometry Approach.

Authors:  Daniele Giovanni Ghiglioni; Piera Anna Martino; Gaia Bruschi; Davide Vitali; Silvia Osnaghi; Maria Grazia Corti; Giangiacomo Beretta
Journal:  Pharmaceutics       Date:  2020-04-20       Impact factor: 6.321

5.  To evaluate the efficacy and safety of olopatadine 0.1% ophthalmic solution and bepotastine 1.5% ophthalmic solution in patients with vernal keratoconjunctivitis in a tertiary care hospital.

Authors:  Vadlakonda Sruthi; Resu Neha Reddy; K Sowmini; Nagur Sharone Grace
Journal:  Indian J Pharmacol       Date:  2020 Nov-Dec       Impact factor: 1.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.